Alzamend Neuro (ALZN) Stock Chart & Stock Price History $2.35 +0.13 (+5.86%) Closing price 04:00 PM EasternExtended Trading$2.40 +0.04 (+1.91%) As of 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alzamend Neuro Stock Price Performance The Alzamend Neuro (ALZN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 84.41%, with a year-to-date return of -77.49%. In the past month, the stock has decreased 2.08%, reflecting recent market activity. As of the latest close, Alzamend Neuro traded at $2.22 with a market cap of $6.97 million and volume of 71,249 shares. Receive ALZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+1.29%1 Month Performance-2.08%3 Month Performance-28.35%Year-To-Date Performance-77.49%1 Year Performance-84.41% ALZN Stock Chart for Monday, October, 20, 2025 ALZN Chart by TradingView Alzamend Neuro Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/20/2025$2.22$2.35+5.86%$2.36$2.2150,317 shs$6.97 million10/17/2025$2.36$2.22-5.93%$2.35$2.1871,249 shs$6.97 million10/16/2025$2.32$2.36+1.72%$2.47$2.2672,444 shs$7.41 million10/15/2025$2.24$2.32+3.57%$2.38$2.2163,709 shs$7.29 million10/14/2025$2.20$2.24+1.82%$2.26$2.1633,961 shs$7.03 million10/13/2025$2.18$2.20+0.92%$2.25$2.1377,383 shs$6.91 million10/10/2025$2.33$2.18-6.44%$2.52$2.15197,499 shs$6.85 million10/09/2025$2.53$2.33-7.91%$2.56$2.32147,555 shs$7.32 million10/08/2025$2.49$2.53+1.61%$2.62$2.42395,449 shs$7.94 million10/07/2025$2.56$2.49-2.73%$2.57$2.48206,016 shs$7.82 million Get the Latest News and Ratings for ALZN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. 10/06/2025$2.53$2.56+1.19%$2.57$2.48191,981 shs$8.04 million10/03/2025$2.47$2.53+2.43%$2.57$2.43358,831 shs$7.94 million10/02/2025$2.45$2.47+0.82%$2.47$2.4265,846 shs$7.76 million10/01/2025$2.38$2.45+2.94%$2.55$2.34177,163 shs$7.69 million09/30/2025$2.36$2.38+0.85%$2.40$2.3368,215 shs$7.47 million09/29/2025$2.41$2.36-2.07%$2.41$2.34116,725 shs$7.41 million09/26/2025$2.36$2.41+2.12%$2.41$2.33130,719 shs$7.57 million09/25/2025$2.38$2.36-0.84%$2.40$2.33110,451 shs$7.41 million09/24/2025$2.35$2.38+1.28%$2.41$2.33164,760 shs$7.47 million09/23/2025$2.37$2.35-0.84%$2.46$2.33181,538 shs$7.38 million09/22/2025$2.40$2.37-1.25%$2.43$2.3268,037 shs$7.44 million09/19/2025$2.49$2.40-3.61%$2.52$2.29295,991 shs$7.54 million Related Companies Dare Bioscience Stock Chart Passage Bio Stock Chart Enlivex Therapeutics Stock Chart Leap Therapeutics Stock Chart MIRA Pharmaceuticals Stock Chart Promis Neurosciences Stock Chart MetaVia Stock Chart Moleculin Biotech Stock Chart AlloVir Stock Chart Aytu BioPharma Stock Chart Receive ALZN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alzamend Neuro and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALZN) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredGold surges past $4,200 … but this has beat gold by 1,000xGold has surged past $4,200 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredNext opportunity for crypto millionsThe floodgates have opened. Bitcoin and Ethereum ETFs are seeing record-breaking inflows, the biggest since...Crypto 101 Media | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredTrump’s “Smart Dollar” just went mainstream"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alzamend Neuro, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alzamend Neuro With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
